First experience with extended release tacrolimus in the treatment of adult patients with severe, difficult to treat atopic dermatitis: Clinical efficacy, safety and dose finding

Jorien van der Schaft; Ron H N van Schaik; Arjan D. van  van Zuilen; Dirk-Jan Hijnen; Maarten Ten Berg; Marcel P H  van den Broek; Carla A F M Bruijnzeel-Koomen; Marjolein S de Bruin-Weller

doi:10.1016/j.jdermsci.2015.10.013

First experience with extended release tacrolimus in the treatment of adult patients with severe, difficult to treat atopic dermatitis: Clinical efficacy, safety and dose finding

Jorien van der Schaft, Ron H N van Schaik, Arjan D. van van Zuilen, Dirk-Jan Hijnen, Maarten Ten Berg, Marcel P H van den Broek, Carla A F M Bruijnzeel-Koomen, Marjolein S de Bruin-Weller

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	66–68
Number of pages	3
Journal	Journal of Dermatological Science
Volume	81
Issue number	1
DOIs	https://doi.org/10.1016/j.jdermsci.2015.10.013
Publication status	Published - 28 Oct 2015

Access to Document

10.1016/j.jdermsci.2015.10.013

Cite this

van der Schaft, J., van Schaik, R. H. N., van Zuilen, A. D. V., Hijnen, D.-J., Berg, M. T., van den Broek, M. P. H., Bruijnzeel-Koomen, C. A. F. M., & de Bruin-Weller, M. S. (2015). First experience with extended release tacrolimus in the treatment of adult patients with severe, difficult to treat atopic dermatitis: Clinical efficacy, safety and dose finding. Journal of Dermatological Science, 81(1), 66–68. https://doi.org/10.1016/j.jdermsci.2015.10.013

@article{c56cdd1b11fe46c98480bbe6956dd119,

title = "First experience with extended release tacrolimus in the treatment of adult patients with severe, difficult to treat atopic dermatitis: Clinical efficacy, safety and dose finding",

author = "{van der Schaft}, Jorien and {van Schaik}, {Ron H N} and {van Zuilen}, {Arjan D. van} and Dirk-Jan Hijnen and Berg, {Maarten Ten} and {van den Broek}, {Marcel P H} and Bruijnzeel-Koomen, {Carla A F M} and {de Bruin-Weller}, {Marjolein S}",

year = "2015",

month = oct,

day = "28",

doi = "10.1016/j.jdermsci.2015.10.013",

language = "English",

volume = "81",

pages = "66–68",

journal = "Journal of Dermatological Science",

issn = "0923-1811",

publisher = "Elsevier Ireland Ltd",

number = "1",

}

van der Schaft, J, van Schaik, RHN, van Zuilen, ADV, Hijnen, D-J, Berg, MT, van den Broek, MPH, Bruijnzeel-Koomen, CAFM & de Bruin-Weller, MS 2015, 'First experience with extended release tacrolimus in the treatment of adult patients with severe, difficult to treat atopic dermatitis: Clinical efficacy, safety and dose finding', Journal of Dermatological Science, vol. 81, no. 1, pp. 66–68. https://doi.org/10.1016/j.jdermsci.2015.10.013

First experience with extended release tacrolimus in the treatment of adult patients with severe, difficult to treat atopic dermatitis: Clinical efficacy, safety and dose finding. / van der Schaft, Jorien; van Schaik, Ron H N; van Zuilen, Arjan D. van et al.
In: Journal of Dermatological Science, Vol. 81, No. 1, 28.10.2015, p. 66–68.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - First experience with extended release tacrolimus in the treatment of adult patients with severe, difficult to treat atopic dermatitis

T2 - Clinical efficacy, safety and dose finding

AU - van der Schaft, Jorien

AU - van Schaik, Ron H N

AU - van Zuilen, Arjan D. van

AU - Hijnen, Dirk-Jan

AU - Berg, Maarten Ten

AU - van den Broek, Marcel P H

AU - Bruijnzeel-Koomen, Carla A F M

AU - de Bruin-Weller, Marjolein S

PY - 2015/10/28

Y1 - 2015/10/28

U2 - 10.1016/j.jdermsci.2015.10.013

DO - 10.1016/j.jdermsci.2015.10.013

M3 - Article

C2 - 26547110

SN - 0923-1811

VL - 81

SP - 66

EP - 68

JO - Journal of Dermatological Science

JF - Journal of Dermatological Science

IS - 1

ER -

van der Schaft J, van Schaik RHN, van Zuilen ADV, Hijnen DJ, Berg MT, van den Broek MPH et al. First experience with extended release tacrolimus in the treatment of adult patients with severe, difficult to treat atopic dermatitis: Clinical efficacy, safety and dose finding. Journal of Dermatological Science. 2015 Oct 28;81(1):66–68. doi: 10.1016/j.jdermsci.2015.10.013